MDMA 'ecstasy' increases cerebral cortical perfusion determined by bolus‐tracking arterial spin labelling (btASL) MRI. (12th June 2013)
- Record Type:
- Journal Article
- Title:
- MDMA 'ecstasy' increases cerebral cortical perfusion determined by bolus‐tracking arterial spin labelling (btASL) MRI. (12th June 2013)
- Main Title:
- MDMA 'ecstasy' increases cerebral cortical perfusion determined by bolus‐tracking arterial spin labelling (btASL) MRI
- Authors:
- Rouine, J
Gobbo, O L
Campbell, M
Gigliucci, V
Ogden, I
McHugh Smith, K
Duffy, P
Behan, B
Byrne, D
Kelly, M E
Blau, C W
Kerskens, C M
Harkin, A - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="bph12178-sec-0001" sec-type="section"> <title>Background and Purpose</title> <p>The purpose of this study was to assess cerebral perfusion changes following systemic administration of the recreational drug 3, 4‐methylendioxymethamphetamine (MDMA 'ecstasy') to rats.</p> </sec> <sec id="bph12178-sec-0002" sec-type="section"> <title>Experimental Approach</title> <p>Cerebral perfusion was quantified using bolus‐tracking arterial spin labelling (btASL) MRI. Rats received MDMA (20 mg·kg<sup>−1</sup>; i.p.) and were assessed 1, 3 or 24 h later. Rats received MDMA (5 or 20 mg·kg<sup>−1</sup>; i.p.) and were assessed 3 h later. In addition, rats received MDMA (5 or 10 mg·kg<sup>−1</sup>; i.p.) or saline four times daily over 2 consecutive days and were assessed 8 weeks later. Perfusion‐weighted images were generated in a 7 tesla (7T) MRI scanner and experimental data was fitted to a quantitative model of cerebral perfusion to generate mean transit time (MTT), capillary transit time (CTT) and signal amplitude.</p> </sec> <sec id="bph12178-sec-0003" sec-type="section"> <title>Key Results</title> <p>MDMA reduces MTT and CTT and increases amplitude in somatosensory and motor cortex 1 and 3 h following administration, indicative of an increase in perfusion. Prior exposure to MDMA provoked a long‐term reduction in cortical 5‐HT concentration, but did not produce a sustained effect on cerebral<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="bph12178-sec-0001" sec-type="section"> <title>Background and Purpose</title> <p>The purpose of this study was to assess cerebral perfusion changes following systemic administration of the recreational drug 3, 4‐methylendioxymethamphetamine (MDMA 'ecstasy') to rats.</p> </sec> <sec id="bph12178-sec-0002" sec-type="section"> <title>Experimental Approach</title> <p>Cerebral perfusion was quantified using bolus‐tracking arterial spin labelling (btASL) MRI. Rats received MDMA (20 mg·kg<sup>−1</sup>; i.p.) and were assessed 1, 3 or 24 h later. Rats received MDMA (5 or 20 mg·kg<sup>−1</sup>; i.p.) and were assessed 3 h later. In addition, rats received MDMA (5 or 10 mg·kg<sup>−1</sup>; i.p.) or saline four times daily over 2 consecutive days and were assessed 8 weeks later. Perfusion‐weighted images were generated in a 7 tesla (7T) MRI scanner and experimental data was fitted to a quantitative model of cerebral perfusion to generate mean transit time (MTT), capillary transit time (CTT) and signal amplitude.</p> </sec> <sec id="bph12178-sec-0003" sec-type="section"> <title>Key Results</title> <p>MDMA reduces MTT and CTT and increases amplitude in somatosensory and motor cortex 1 and 3 h following administration, indicative of an increase in perfusion. Prior exposure to MDMA provoked a long‐term reduction in cortical 5‐HT concentration, but did not produce a sustained effect on cerebral cortical perfusion. The response to acute MDMA challenge (20 mg·kg<sup>−1</sup>; i.p.) was attenuated in these animals indicating adaptation in response to prior MDMA exposure.</p> </sec> <sec id="bph12178-sec-0004" sec-type="section"> <title>Conclusions and Implications</title> <p>MDMA provokes changes in cortical perfusion, which are quantifiable by btASL MRI, a neuroimaging tool with translational potential. Future studies are directed towards elucidation of the mechanisms involved and correlating changes in cerebrovascular function with potential behavioural deficits associated with drug use.</p> </sec> </abstract> … (more)
- Is Part Of:
- British journal of pharmacology. Volume 169:Number 5(2013:Jul.)
- Journal:
- British journal of pharmacology
- Issue:
- Volume 169:Number 5(2013:Jul.)
- Issue Display:
- Volume 169, Issue 5 (2013)
- Year:
- 2013
- Volume:
- 169
- Issue:
- 5
- Issue Sort Value:
- 2013-0169-0005-0000
- Page Start:
- 974
- Page End:
- 987
- Publication Date:
- 2013-06-12
- Subjects:
- Pharmacology -- Periodicals
Chemotherapy -- Periodicals
Drug Therapy -- Periodicals
Pharmacology -- Periodicals
615.1 - Journal URLs:
- http://bibpurl.oclc.org/web/21844 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1476-5381/issues ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=282&action=archive ↗
http://onlinelibrary.wiley.com/ ↗
http://www.nature.com/bjp/index.html ↗ - DOI:
- 10.1111/bph.12178 ↗
- Languages:
- English
- ISSNs:
- 0007-1188
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2314.700000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4098.xml